author-photo

Jerzy Swierkot

Wrocław Medical University

95

Papers

589

Citations

Citation Trend

Filter By

Papers (69) Sort By

Journal Conference Others

POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies.

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis.

2021 Mediators of Inflammation
Show All
- Source
- Cite
- Save
Citations (0)
Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis

2021 Central European Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (1)
Sekukinumab w leczeniu pacjentów z osiową i obwodową spondyloatropatią — aktualizacja stanowiska ekspertów Polskiego Towarzystwa Reumatologicznego

2021
Show All
- Source
- Cite
- Save
Citations (0)
Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors

2021 Disease Markers
Show All
- Source
- Cite
- Save
Citations (0)
Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients

2021 Pharmacogenomics and Personalized Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (0)
IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (1)
THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (2)